Rethinking Rx-Dx Codevelopment

Sponsor: Molecular MD. Codevelopment is an intermittent and uncertain process. Adopting an agnostic approach to the challenges associated with platform and method selection provide added degrees of freedom for strategic development and selection of the most appropriate clinical trial assay.

Liquid Biopsy and ddPCR: A Match with Quality in Mind

Sponsor: Bio Rad. In this webinar we will hear how GenQA addresses some of the challenges in providing quality assessments for ctDNA testing.

Advancing Mass Spectrometry-Based Large-Cohort Proteomics for Precision Medicine

Sponsor: ThermoFisher Scientific. Large cohort studies are essential to the discovery of protein biomarkers, and their validation is indispensable to clinical utility.

Immunotherapy and Cancer: Harnessing the Power of Diagnostic Assays

Sponsor: MolecularMD. In this eBook learn how MolecularMD is harnessing the company's unique capabilities to address diagnostic needs within immuno-oncology.

How Multi-Omics Profiling Can Redefine Precision Health and Medicine

Sponsor: ThermoFisher Scientific. Coupling relatively routine datasets such as genomes and transcriptomes with newer types produces an “integrative Personal Omics Profile".

Rise of Genomics in Clinical Trials

Sponsor: DNAnexus. The challenges of incorporating NGS into clinical trials is being addressed through the adoption of robust technology solutions.

Multiplexed Mass Spectrometry Solutions for Cancer Proteomics

Sponsor: ThermoFisher Scientific. In this webinar, multiplexing quantitative proteomics for profiling breast cancer patient-derived xenografts will be discussed.
video

Addressing Challenges of NGS Data Interpretation for Hematologic Malignancies

Sponsor: QIAGEN. This groundbreaking webinar will discuss how NGS technologies have aided clinicians in the diagnosis and treatment of hematologic cancer.
video

The Promise and Challenge of Immuno-Oncology

Sponsor: QIAGEN. This webinar explores the complexity of diagnostic testing in immuno-oncology and therapeutic innovations that have emerged in the field.

Conquering CML: The Breakthrough Paradigm Change of Treatment-free Remission

Sponsor: MolecularMD. Download this eBook to learn how MolecularMD helped usher in a new era of CML treatment now prescribed by progressive clinicians.
Scroll Up